Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Targeted Cancer Therapies

Cancer Classification

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Epidemiology

Using Biomarkers to Detect Cancer

Cancer Glossary

Hypoxia Markers and Their Importance

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Symptoms

See more featured articles »

What Role do Biobanks Play in Cancer Research?

Why are Cancer Cell Lines Useful?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Management

What Causes Cancer?

Cancer Pain

Secondary Brain Cancer

British Pioneers in Cancer Biology

What is Cancer of Unknown Primary?

TARDIS: The Improved Method of Detecting Breast Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

What is the Tumor Microenvironment?

The Effects of Cancer on Family Life

Overview of Cell Viability and Cytotoxicity

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cutaneous Manifestations of Internal Malignancy

Caring for a Loved One with Cancer

Microfluidic cancer treatment screen combined with flow cytometry

What is Immunochemotherapy?

What is Cancer?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Pain Management

CDK9 and Cancer

The Cancer Cell Surface Proteome as a Therapeutic Target

Myc Mutations and Cancer

Pediatric Cancer

Transforming Cancer Care through Genomic Testing

Cancer History

Cancer Pathophysiology

Insight into Cancer Vaccines

Cancer Research

Effects of Social and Economic Deprivation on Cancer Mortality

Hot vs Cold: the differences between tumor types

Cancer Prognosis

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

What is Tumorigenesis?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Metastatic Migration in Cancer may be Influenced by Metabolism

Secondary Lung Cancer

Cancer Prevention: Lowering your Risk

What is Merkel Cell Carcinoma?

Living with Cancer Pain

Investigating the Molecular Mechanisms of Cancer

Acidosis and Tumor Progression

Cancer Diagnosis

The Biochemistry of Breast Cancer Screening

Insights into Oncofertility

Is Cancer a Metabolic Disorder?

Extracellular Vesicles as Floating Cancer Biomarkers

Latest Cancer News and Research

Lung Facts updated with latest evidence on respiratory disease across 21 countries

The International Respiratory Coalition (IRC) has updated its Lung Facts platform with the latest evidence on the burden of respiratory disease across 21 countries, providing policymakers, clinicians and patient advocates with updated data to drive national-level policy action on lung health.

16 Sep 2026

Novel blood test could detect pancreatic cancer at its earliest stages

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the country, led the development of a new, investigational blood test that could detect pancreatic cancer at its earliest stages, when the disease is more treatable and potentially curable.

16 Sep 2026

Promising AI tool to speed up endometriosis diagnosis

Less than a second. That’s how long it takes for an emerging AI tool to detect signs of endometriosis through one simple scan. It’s a much faster process than the current seven-year wait for surgery and less invasive.

16 Sep 2026

ACROBiosystems deepens its France presence with a dedicated hub at The HIVE Innovation Center, embedding into the Campus Grand Parc ecosystem

Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life sciences, situated on the Campus Grand Parc in Villejuif.

From ACROBiosystems 16 Sep 2026

Biological mechanisms validate structured exercise as therapeutic in oncology care

Structured exercise may help people with cancer live longer and have more time free of disease, finds a synthesis of the available evidence, published online in the British Journal of Sports Medicine.

16 Sep 2026

Researchers build prognostic model to guide end-of-life care in metastatic breast cancer

Oncologists know that intensive treatment rarely helps patients in their final days but recognizing when someone is entering that stage is difficult, especially in metastatic breast cancer, where an increasing number of effective treatments has helped prolong life and given patients and oncologists more treatment options.

16 Sep 2026

Finnish adults eat too little of some foods and too much of others, study finds

Analysis of dietary data from 1,655 Finnish adults found that usual food intake often differed substantially from the quantitative targets later set by the Nordic Nutrition Recommendations 2023. Plant-based foods were generally underconsumed, while red and processed meat and dairy intake frequently exceeded study targets, with adherence varying by sex, education, physical activity, age, and energy intake.

16 Sep 2026

New 3D structure reveals how cancer-linked BRD4 protein binds to chromosomes

A new 3D-structure of a cancer-linked protein bound to its cellular partner reveals details of how the protein binds to chromosomes and could offer insights for future disease treatments.

15 Sep 2026

Harvard scientists design evolutionary traps to stop viral mutations

When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS‑CoV‑2 can slip past vaccines and antibody drugs before scientists fully understand what has changed.

15 Sep 2026

Cardiovascular disease surpasses cancer as top killer of Hispanic populations in the U.S.

Cardiovascular disease has surpassed cancer as the leading cause of death among Hispanic adults in the U.S., driven by rising rates of obesity, diabetes, high blood pressure and other risk factors that often begin earlier in life for Hispanic people.

15 Sep 2026

Study uncovers how interferon-alpha treats rare blood cancers

The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators.

15 Sep 2026

Insilico Medicine launches AI initiative to develop longevity vaccines

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced Longevity Vaccines, a research initiative developing treatments that direct a patient's own immune cells to eliminate the earliest cellular drivers of age-related disease.

15 Sep 2026

US Medicare's new 'Most-Favored-Nation' pricing policy could raise international medicine prices

A new modeling study published in The Lancet suggests that US Medicare's new 'Most-Favored-Nation' pricing policy, which ties what Medicare pays for medicines to prices charged in other high-income countries, could push pharmaceutical manufacturers to raise prices or delay launches.

15 Sep 2026

Study provides a clearer picture of the extent of overdiagnosis in breast cancer screening

When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have caused symptoms or problems during their lifetime. This is known as overdiagnosis.

15 Sep 2026

Wearable electroceutical platform enables remote wireless pain management

A "wearable electroceutical" has been developed that could reduce the need to visit a hospital or rely on painkillers every time pain occurs.

15 Sep 2026

Genomic profiling uncovers distinct TP53 and PI3K pathways across tumor budding grades

A newly proposed International Association for the Study of Lung Cancer (IASLC) tumor budding-based grading system successfully identified patients with resected lung squamous cell carcinoma (SqCC) at higher risk of poor outcomes and showed potential to help guide selection for adjuvant chemotherapy, according to research presented at the IASLC 2026 World Conference on Lung Cancer on Lung Cancer. (WCLC).

15 Sep 2026

Stage 1 findings support continued pivotal phase evaluation of gotistobart

Patients with metastatic squamous non-small cell lung cancer (NSCLC) whose disease progressed following PD-(L)1 inhibitor therapy experienced a median overall survival of 18.5 months with the investigational anti-CTLA-4 antibody gotistobart compared with 10.0 months for patients receiving docetaxel, according to updated findings from Stage 1 of the Phase 3 PRESERVE-003 trial.

15 Sep 2026

Mobile LDCT lung cancer screening can reach vulnerable populations in resource-limited settings

Mobile low-dose computed tomography (LDCT) screening can reach high-risk and socially vulnerable populations in resource-limited settings, according to initial results from the Third Brazilian Early Lung Cancer Trial (BRELT3) presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

15 Sep 2026

Research identifies novel prognostic biomarkers for class II and III BRAF-altered cancers

Patients with metastatic non-small cell lung cancer (NSCLC) harboring class II and class III BRAF alterations have distinct clinicopathologic and genomic characteristics, with class III alterations potentially associated with worse prognosis, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

15 Sep 2026

Early consolidative SRT shows value in EGFR-mutant NSCLC with limited brain metastases

Early cranial stereotactic radiotherapy (SRT) administered with first-line osimertinib was associated with improved intracranial control and survival outcomes in patients with EGFR-mutant non-small cell lung cancer (NSCLC) and limited brain metastases, according to research presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

15 Sep 2026